IP Library Granted Patent US 12,420,072
Granted Patent B2
US 12,420,072 · App. 17/883,302 · Granted Sep 23, 2025

Systems and methods for cross-linking treatments of an eye

Inventors: Marc D. Friedman (Needham, MA); Alexandra Nicklin (Cambriedge, MA); Pavel Kamaev (Lexington, MA)
Assignee: Avedro, Inc.
A61M37/00A61F9/0017A61F9/007A61F9/008A61F9/00802A61F9/00804A61N5/062A61F2009/00844A61F2009/00872A61F2009/00893A61F2009/00895A61M2037/0007A61M2037/0046A61M2205/051A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,420,072
App. No.
17/883,302
Granted
Sep 23, 2025
Kind
B2
Abstract

Example eye treatments detennine an area at a surface of a cornea for delivery of a cross-linking agent. The example treatments disrupt tissue at the area at the surface of the con1ea up to a depth corresponding to apical layers of superficial squamous cells of the cornea, e.g., no greater than approximately 10 μm to approximately 15 lm. The example treatments apply a cross-linking agent to the area at the surface of the cornea. The cross-linking agent is transmitted through the disrupted area at a greater rate relative to non disrupted areas of the cornea. The example treatments deliver photoactivating light to the cornea. The photoactivating light activates the cross-linking agent to generate cross-linking activity in the cornea.

Claims (28)

1. A method for treating an eye, comprising:

determining an area at a surface of a cornea for delivery of a cross-linking agent;

disrupting tissue at the area at the surface of the cornea for partial epithelial disruption, including disrupting apical layers of superficial squamous cells of the cornea, wherein the disrupting the tissue at the area at the surface of the cornea includes disrupting the cornea up to a depth of no greater than approximately 25 μm;

applying a cross-linking agent to the area at the surface of the cornea, the cross-linking agent being transmitted through a disrupted area at a greater rate relative to non-disrupted areas of the cornea; and

delivering photoactivating light to the cornea, the photoactivating light activating the cross-linking agent to generate cross-linking activity in the cornea.

2. The method of claim 1 , wherein disrupting the tissue at the area at the surface of the cornea includes ablating the area with a laser.

3. The method of claim 1 , wherein disrupting the tissue at the area at the surface of the cornea includes moving a disruption element over the surface of the cornea, the disruption element including a disruption surface configured to contact the cornea and disrupt the tissue at the area at the surface of the cornea.

4. The method of claim 3 , wherein the disruption surface includes a pattern of micro-teeth.

5. The method of claim 3 , wherein the disruption element includes a sponge material.

6. The method of claim 3 , wherein the disruption element is biased against the cornea via a constant force spring.

7. The method of claim 3 , wherein the disruption element is configured for two-dimensional movement, including lateral translation over the cornea.

8. The method of claim 1 , wherein the disrupting the tissue at the area at the surface of the cornea includes disrupting the tissue uniformly across the depth of the area.

9. A method for treating an eye, comprising:

determining an area at a surface of a cornea for delivery of a cross-linking agent;

disrupting tissue at the area at the surface of the cornea with a disruption element for partial epithelial disruption, including disrupting apical layers of superficial squamous cells of the cornea, wherein the disrupting the tissue at the area at the surface of the cornea includes disrupting the cornea up to a depth of no greater than approximately 25 μm;

applying a cross-linking agent to the area at the surface of the cornea; and

delivering photoactivating light to the cornea, the photoactivating light activating the cross-linking agent to generate cross-linking activity in the cornea.

10. The method of claim 9 , wherein disrupting the tissue at the area at the surface of the cornea includes ablating the area with a laser.

11. The method of claim 9 , wherein disrupting the tissue at the area at the surface of the cornea includes moving the disruption element over the surface of the cornea, the disruption element including a disruption surface configured to contact the cornea and disrupt the tissue at the area at the surface of the cornea.

12. The method of claim 11 , wherein the disruption surface includes a pattern of micro-teeth.

13. The method of claim 9 , wherein the disruption element includes a sponge material.

14. The method of claim 9 , wherein the disruption element is biased against the cornea via a constant force spring.

15. The method of claim 9 , wherein the disrupting the tissue at the area at the surface of the cornea includes disrupting the tissue uniformly across the depth of the area.

16. The method of claim 9 , wherein the cross-linking agent is transmitted through a disrupted area at a greater rate relative to non-disrupted areas of the cornea.

17. A method for treating an eye, comprising:

disrupting tissue an area at a surface of a cornea with a disruption element, including disrupting apical layers of superficial squamous cells of the cornea, wherein the disrupting the tissue at the area at the surface of the cornea includes disrupting the cornea up to a depth of no greater than approximately 25 μm;

applying a cross-linking agent to the area at the surface of the cornea, the cross-linking agent being transmitted through a disrupted area at a greater rate relative to non-disrupted areas of the cornea; and

delivering photoactivating light to the cornea, the photoactivating light activating the cross-linking agent to generate cross-linking activity in the cornea.

Continuity (4)
Division 16324489
Provisional Application 62433053 · Dec 12, 2016
Provisional Application 62372290 · Aug 8, 2016
Related Publication 20230129652A1 · Apr 27, 2023
References Cited (3)
US 5699810A · Pallikaris · 1997 [cited by examiner]
US 6132421A · Clapham · 2000 [cited by examiner]
US 20110288466A1 · Muller · 2011 [cited by examiner]